<DOC>
	<DOC>NCT01211808</DOC>
	<brief_summary>The purpose of this study is to assess the effects of diltiazem on the pharmacokinetics of single-dose BMS-914392 in healthy subjects.</brief_summary>
	<brief_title>Effect of Diltiazem on Pharmacokinetics of BMS-914392</brief_title>
	<detailed_description>Protocol designed to evaluate the potential for a drug-drug interaction</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<criteria>Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations Women of childbearing potential (WOCBP) and men must be using an acceptable method of contraception to avoid pregnancy Current or recent (within 3 months of study drug administration) gastrointestinal disease Current or history of neurological diseases or psychiatric disorders and cardiovascular diseases</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>